DR Horton, Inc. (NYSE:DHI) Director Michael W. Hewatt sells 1,948 shares


DR Horton, Inc. (NYSE: DHIGet a rating) Director Michael W. Hewatt sold 1,948 shares in a trade on Wednesday, May 25. The shares were sold at an average price of $67.97, for a total value of $132,405.56. As a result of the sale, the administrator now directly owns 5,067 shares of the company, valued at approximately $344,403.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, accessible via this hyperlink.

DHI traded at $3.86 during Thursday’s trading, reaching $72.86. 4,970,504 shares of the company have been traded, against an average volume of 3,857,729. The company has a current ratio of 5.95, a quick ratio of 0.98 and a debt ratio of 0.33. DR Horton, Inc. has a 1-year low of $64.13 and a 1-year high of $110.45. The stock has a 50-day moving average price of $73.02 and a 200-day moving average price of $86.91. The company has a market cap of $25.65 billion, a P/E ratio of 5.16, a price-to-earnings growth ratio of 0.46, and a beta of 1.59.

DR Horton (NYSE: DHIGet a rating) last released its quarterly earnings data on Tuesday, April 26. The construction company reported earnings per share (EPS) of $4.03 for the quarter, beating the consensus estimate of $3.37 by $0.66. DR Horton had a net margin of 16.53% and a return on equity of 32.22%. The company posted revenue of $8 billion in the quarter, versus a consensus estimate of $7.64 billion. In the same period a year earlier, the company earned earnings per share of $2.53. DR Horton’s revenue for the quarter increased 24.1% year over year. Analysts expect DR Horton, Inc. to post earnings per share of 17.37 for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 18. Shareholders of record on Monday, May 9 received a dividend of $0.225 per share. The ex-dividend date was Friday, May 6. This represents an annualized dividend of $0.90 and a yield of 1.24%. DR Horton’s dividend payout ratio is currently 6.45%.

A number of analysts have recently commented on the company. Credit Suisse Group took over DR Horton’s coverage in a Tuesday, April 5 research note. They set a “neutral” rating and a price target of $89.00 on the stock. Citigroup reduced its target price on DR Horton from $108.00 to $97.00 in a Friday, March 25 research report. JPMorgan Chase & Co. cut its price target on DR Horton from $100.00 to $82.50 and set an “overweight” rating on the stock in a Wednesday, April 13 research report. Barclays reduced its target price on DR Horton from $125.00 to $104.00 in a Thursday, March 31 research report. Finally, Goldman Sachs Group cut its price target on DR Horton from $120.00 to $83.00 and set a “neutral” rating on the stock in a Tuesday, April 12 research report. Four research analysts gave the stock a hold rating, ten gave the stock a buy rating and one gave the stock a strong buy rating. According to MarketBeat.com, DR Horton currently has an average rating of “Buy” and a consensus target price of $103.65.

A number of institutional investors and hedge funds have recently increased or reduced their stakes in the company. Vanguard Group Inc. increased its stake in DR Horton by 1.1% during the first quarter. Vanguard Group Inc. now owns 35,902,967 shares of the construction company worth $2,675,130,000 after purchasing an additional 406,429 shares during the period. Capital World Investors increased its equity stake in DR Horton by 176.2% in the first quarter. Capital World Investors now owns 17,819,619 shares of the construction company valued at $1,327,740,000 after purchasing an additional 11,369,033 shares during the period. State Street Corp increased its stake in DR Horton shares by 3.2% in the fourth quarter. State Street Corp now owns 15,458,390 shares of the construction company valued at $1,676,462,000 after purchasing an additional 477,354 shares during the period. Bank of America Corp DE increased its stake in DR Horton shares by 8.9% in the fourth quarter. Bank of America Corp DE now owns 6,878,990 shares of the construction company valued at $746,027,000 after purchasing an additional 560,536 shares during the period. Finally, Geode Capital Management LLC increased its stake in DR Horton shares by 4.8% in the fourth quarter. Geode Capital Management LLC now owns 6,480,995 shares of the construction company valued at $701,101,000 after purchasing an additional 298,927 shares during the period. Institutional investors hold 81.27% of the company’s shares.

DR Horton Company Profile (Get a rating)

DR Horton, Inc operates as a residential construction company in the eastern, northern, southeast, south-central, southwest, and northwest regions of the United States. It deals with the acquisition and development of land; and building and selling residential homes in 31 states and 98 markets under the DR names

Read more

Insider buying and selling by quarter for DR Horton (NYSE:DHI)



Get news and reviews for DR Horton Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for DR Horton and related companies with MarketBeat.com’s FREE daily newsletter.

Comments are closed.